Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.49 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19288051 | 1.00 | NAAA (0.49) | NAAAHTR2CPRSS1PRSS2PRSS3 | |
| SCHEMBL27873998 | 0.94 | ATM (0.41) | NAAAHTR2CPRSS1PRSS2PRSS3 | |
| SCHEMBL4889294 | 0.92 | NAAA (0.56) | NAAAHTR2CNPSR1RAD52FAAH | |
| SCHEMBL4889296 | 0.87 | NAAA (0.50) | NAAAHTR2CNPSR1RAD52FAAH | |
| SCHEMBL27857355 | 0.81 | CACNA2D1 (0.39) | TSHR | |
| SCHEMBL21589071 | 0.81 | CACNA2D1 (0.39) | TSHR | |
| SCHEMBL4329152 | 0.81 | CACNA2D1 (0.39) | TSHR | |
| SCHEMBL20097532 | 0.80 | CACNA2D1 (0.51) | NAAAHTR2CPRSS1PRSS2PRSS3 | |
| SCHEMBL27560470 | 0.80 | ATM (0.44) | NAAAHTR2CNPSR1RAD52FAAH | |
| SCHEMBL4886378 | 0.79 | NAAA (0.45) | NAAAHTR2CNPSR1RAD52FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170334836-A1 | METHOD FOR PREPARING 3-CARBAMOYMETHYL-5-METHYLHEXANOIC ACID IN RECYCLING WAY | ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (CN) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170334836-A1 | METHOD FOR PREPARING 3-CARBAMOYMETHYL-5-METHYLHEXANOIC ACID IN RECYCLING WAY | ALKBH5, ALKBH3, ALKBH1 | NAAA 265/4885HTR2C 584/4885PRSS1 4427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.